市場調查報告書
商品編碼
391483

生物性保存技術的全球市場:成長,趨勢,及預測(2019年∼2024年)

Biopreservation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球生物性保存技術市場在2019年∼2024年間預測將以15.3%的年複合成長率成長。

本報告提供全球生物性保存技術市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,產品·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的假設
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 生物性保存技術培養基
    • 設備
  • 各用途
    • 生物銀行
    • 再生醫療
    • 藥物研發
    • 其他
  • 各終端用戶
    • 生物銀行
    • 醫院
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • BioCision LLC
    • BioLife Solutions Inc.
    • Cesca Therapeutics Inc.
    • Core Dynamics Ltd
    • Custom Biogenic Systems Inc.
    • Lifeline Scientific Inc.
    • Merck KGaA
    • Princeton CryoTech Inc.
    • VWR International

第7章 市場機會及未來趨勢

目錄
Product Code: 46219

Key Highlights

  • The biopreservation market is expected to witness a CAGR of 15.3% during the forecast period. Certain factors driving the market growth include improving healthcare expenditure, adoption of in-house sample storage in hospitals and labs, and increasing R&D investment.
  • Healthcare expenditure continues to increase faster than economic growth in most countries, maintaining a trend observed over the decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, and Asia Pacific has also contributed to the maximum possible share of GDP being utilized for healthcare expenditure. Biopreservation has broad public health and socio-economic impacts, and it is affecting many lives across the world. It has been widely used to preserve cells and tissues, targeting its reproductive medicine and organ transplantation applications. Stem cell banking and gene banking have also gained global popularity.
  • With the growing healthcare expenditure each year, the government collaborations with companies and universities for better exposure to the technology used and its development for higher efficiency are increasing. With growing technological advancements in biopreservation and healthcare equipment, along with the cost-effectiveness of these instruments, a major share of healthcare spending is going to be invested in this domain.
  • However, concerns with the transition from laboratory to the market include the major problems of preservation and storage of tissues or cells. Despite the protection, the processes of freezing and thawing often cause tissue damage or cell injury. This factor hinders the growth of the market potential of biopreservation. Tissue cryopreservation is highly complicated and difficult than cryopreservation of individual cells. Injuries to cells during freezing and thawing are related to the physicochemical and biophysical changes that occur during cryopreservation.

Key Market Trends

Biopreservation Media is Expected to Hold Significant Market Share in the Product Type Segment

Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early-stage of stem cell culture depends on a continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects.

Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of the liver, lungs, pancreas, heart, and kidney.

North America Dominates the Market and Expected to do Same in the Forecast Period

The North American market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues (like peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives), across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in this region, which is supporting the sharing of biological samples.

Competitive Landscape

The biopreservation market is highly competitive and consists of several major players. Companies, like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International, hold a substantial market share in the market studied.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Improving Healthcare Expenditure
    • 4.2.2 Adoption of In-house Sample Storage in Hospitals and Labs
    • 4.2.3 Increasing R&D Investment
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Instruments and its Maintenance
    • 4.3.2 Possibility of Tissue Injury During Preservation and Thawing
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Products
    • 5.1.1 Biopreservation Media
    • 5.1.2 Equipment
      • 5.1.2.1 Temperature Maintaining Units
      • 5.1.2.2 Consumables
      • 5.1.2.3 Other Equipment
  • 5.2 By Application Area
    • 5.2.1 Biobanking
    • 5.2.2 Regenerative Medicine
    • 5.2.3 Drug Discovery
    • 5.2.4 Other Application Areas
  • 5.3 By End User
    • 5.3.1 Biobanks
    • 5.3.2 Hospitals
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 BioCision LLC
    • 6.1.2 BioLife Solutions Inc.
    • 6.1.3 Cesca Therapeutics Inc.
    • 6.1.4 Core Dynamics Ltd
    • 6.1.5 Custom Biogenic Systems Inc.
    • 6.1.6 Lifeline Scientific Inc.
    • 6.1.7 Merck KGaA
    • 6.1.8 Princeton CryoTech Inc.
    • 6.1.9 VWR International

7 MARKET OPPORTUNITIES AND FUTURE TRENDS